Elevation Oncology Statistics
Total Valuation
AVB has a market cap or net worth of $26.98 billion. The enterprise value is $35.54 billion.
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
AVB has 143.32 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | 143.32M |
| Shares Outstanding | 143.32M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 94.67% |
| Float | 142.54M |
Valuation Ratios
The trailing PE ratio is 23.15 and the forward PE ratio is 34.51. AVB's PEG ratio is 5.67.
| Price/FFO Ratio | 16.97 |
| Price/AFFO Ratio | n/a |
| PE Ratio | 23.15 |
| Forward PE | 34.51 |
| PS Ratio | 8.82 |
| Forward PS | 8.52 |
| PB Ratio | 2.22 |
| P/TBV Ratio | 2.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 5.67 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 30.69 |
| EV / Sales | 11.72 |
| EV / EBITDA | 19.38 |
| EV / EBIT | 36.61 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.71.
| Current Ratio | 0.98 |
| Quick Ratio | 0.34 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 4.72 |
| Debt / FCF | n/a |
| Interest Coverage | 4.15 |
Financial Efficiency
Return on equity (ROE) is 9.71% and return on invested capital (ROIC) is 2.95%.
| Return on Equity (ROE) | 9.71% |
| Return on Assets (ROA) | 2.83% |
| Return on Invested Capital (ROIC) | 2.95% |
| Return on Capital Employed (ROCE) | 4.51% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | $387,485 |
| Employee Count | 2,988 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -118,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.00% in the last 52 weeks. The beta is 0.87, so AVB's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -10.00% |
| 50-Day Moving Average | 201.54 |
| 200-Day Moving Average | 213.14 |
| Relative Strength Index (RSI) | 36.91 |
| Average Volume (20 Days) | 866,495 |
Short Selling Information
The latest short interest is 3.16 million, so 2.20% of the outstanding shares have been sold short.
| Short Interest | 3.16M |
| Short Previous Month | 3.09M |
| Short % of Shares Out | 2.20% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 3.38 |
Income Statement
In the last 12 months, AVB had revenue of $3.03 billion and earned $1.16 billion in profits. Earnings per share was $8.13.
| Revenue | 3.03B |
| Gross Profit | 1.93B |
| Operating Income | 970.64M |
| Pretax Income | 848.11M |
| Net Income | 1.16B |
| EBITDA | 1.83B |
| EBIT | 970.64M |
| Earnings Per Share (EPS) | $8.13 |
Full Income StatementBalance Sheet
The company has $102.83 million in cash and $8.66 billion in debt, giving a net cash position of -$8.56 billion or -$59.71 per share.
| Cash & Cash Equivalents | 102.83M |
| Total Debt | 8.66B |
| Net Cash | -8.56B |
| Net Cash Per Share | -$59.71 |
| Equity (Book Value) | 12.17B |
| Book Value Per Share | 84.91 |
| Working Capital | -6.56M |
Full Balance SheetMargins
Gross margin is 63.58%, with operating and profit margins of 32.00% and 38.24%.
| Gross Margin | 63.58% |
| Operating Margin | 32.00% |
| Pretax Margin | 38.28% |
| Profit Margin | 38.24% |
| EBITDA Margin | 60.47% |
| EBIT Margin | 32.00% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $7.00, which amounts to a dividend yield of 3.72%.
| Dividend Per Share | $7.00 |
| Dividend Yield | 3.72% |
| Dividend Growth (YoY) | 2.99% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 84.85% |
| Buyback Yield | -0.35% |
| Shareholder Yield | 3.37% |
| Earnings Yield | 4.29% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for AVB is $228.93, which is 21.62% higher than the current price. The consensus rating is "Hold".
| Price Target | $228.93 |
| Price Target Difference | 21.62% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 6.04% |
| EPS Growth Forecast (5Y) | -2.58% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
